Home
Search:
1146 feeds
357 categories
0 articles (<24 hours)
35 registered users

Use the Mobile version
Mobile

Follow our Twitter feed

View our Linkpartners
Links

Username:
Password:

Register | Retrieve

General


RSS FeedsGalapagos announces new Phase 2 Proof-of-Concept studywith filgotinib in cutaneous lupus erythematosus
(WorldNews Belgium)

 
 

25 april 2017 23:19:06

 
Galapagos announces new Phase 2 Proof-of-Concept studywith filgotinib in cutaneous lupus erythematosus
(WorldNews Belgium)
 


Press release Galapagos announces new Phase 2 Proof-of-Concept study with filgotinib in cutaneous lupus erythematosus Mechelen, Belgium; 25 April 2017, 22.00 CET - Galapagos NV (Euronext & NASDAQ: GLPG) announces a new Phase 2 Proof-of-Concept study investigating filgotinib and another investigational agent in cutaneous lupus erythematosus (CLE). This study is being led by filgotinib collaboration partner Gilead Sciences, Inc. "We are very excited with the initiation of this Proof-of-Concept study with filgotinib in CLE. This is the first time we evaluate filgotinib in an autoimmune skin disorder, and specifically, one with a significant unmet need," said Dr. Walid Abi-Saab,...


 
3 viewsCategory: General > Europe > Belgium
 
UPDATE 3-McDonald`s profit beats as turnaround gains steam, shares at record high
(WorldNews Belgium)
Why Flanders is the perfect fit for a family road trip
(WorldNews Belgium)
 
 
blog comments powered by Disqus


Copyright © 2008 - 2024 Indigonet Services B.V.. Contact: Tim Hulsen. Read here our privacy notice.
Other websites of Indigonet Services B.V.: Nieuws Vacatures Science Tweets Nachrichten